MCF-7
2.1. bioinks, 2.1.1. alginate-based bioinks.
Alginate is a polysaccharide mainly derived from brown algae and bacteria and is, widely used in bioprinting because of its excellent biocompatibility, low cost, rapid gelation, good printability, and versatility [ 84 , 85 ]. Alginate-based bioinks typically refer to bioinks containing alginate, which can be prepared by adding components such as alginate, crosslinkers, and cell suspensions. This type of bioink is commonly used in 3D printing systems. During the preparation process, alginate can serve as the scaffold material for the bioink, providing structural support and a conducive environment for cell growth. A low concentration of alginate-based bioink promotes cell activity and proliferation, but significantly reduces the mechanical strength of the 3D printed structure, leading to structural collapse. Conversely, a high concentration of alginate-based bioink decreases cell viability [ 86 ], limiting its application in simulating tumor organ formation. Moreover, alginate forms chemical crosslinks with divalent cations such as calcium (Ca 2+ ), strontium (Sr 2+ ), and barium (Ba 2+ ), resulting in immediate gelation, with the sol-gel transition temperature being below 0 °C. Therefore, using alginate as a standalone bioactive material for bioprinting is difficult. Typically, substances such as gelatin are added as physical crosslinking agents to enhance the stability of printed structures. Bioinks that form a fixed structural network through crosslinking to enhance stability and shape retention prior to printing are referred to as pre-crosslinked bioinks. Pre-crosslinked bioinks form a structurally stable scaffold during the printing process and provide a conducive environment for cell growth [ 49 ].
Owing to their excellent biocompatibility, rapid biodegradability, and chemical gelation properties, pre-crosslinked alginate-based bioinks can be bioprinted using extrusion-based methods to construct soft-tissue tumor organoid models, such as breast tumors, glioblastomas, and lung tumors. Alternatively, 3D vascularized tissue models with controllable vessel wall thicknesses can be printed using coaxial nozzle-assisted crosslinking [ 87 , 88 ].
Gelatin is a biologically sourced material obtained through the acidic or alkaline hydrolysis of collagen. It is a readily available water-soluble and highly biodegradable polypeptide that exhibits good biocompatibility [ 89 ]. At 28 °C, gelatin demonstrates unique thermally reversible gelation behavior, enabling the temperature or concentration of cell-loaded gelatin solutions to be conveniently adjusted to achieve the desired 3D printing structure [ 90 , 91 ], making it particularly attractive as a bioink. Therefore, gelatin-based hydrogels with specific thermo-responsive properties enable cells and bioactive substances to be extruded through the nozzle or needle of a 3D bioprinter. In this way, they can be stacked into layers in a relatively mild environment to form predefined 3D structures that support cell growth while maintaining extremely high cell viability. The versatility, biocompatibility, and high bioactivity of gelatin-based bioinks are widely utilized in high-throughput drug screening and the creation of organotypic tumor models with specific tissue structures.
However, the poor mechanical properties of gelatin limit its application as a bioink. The stability of printed structures can be improved by adding alginate and fibronectin and forming chemical crosslinks in gelatin-based bioinks [ 92 ]. By adding modifiers, gelatin-based bioinks can serve as both a support structure and a source of RGD peptides [ 93 , 94 ], providing the necessary biological signals for tumor cell migration. As a cell adhesion sequence, RGD peptide can bind with integrins on the cell surface, thereby enhancing cell adhesion and interactions within the biological scaffold. This simulated cell-matrix interaction contributes to better understanding and studying the mechanisms of tumor cell migration and invasion, providing crucial guidance and insights to unravel the process of tumor metastasis [ 95 , 96 ].
The amino groups in gelatin can be chemically modified with methacrylamide groups (such as chloro-methacrylate, glycerol methacrylate, and methacrylic anhydride) to form a hybrid gelatin-methacrylate hydrogel [ 97 ], which enhances the adhesion and printability of bioinks under physiological conditions [ 98 ]. Owing to the presence of an Arg-Gly-Asp (RGD) sequence and matrix metalloproteinase (MMP) degradable motifs in the polymer chain, GelMA demonstrates strong cell adhesion and migration capabilities. The cross-linking of functional groups added to the gelatin backbone by photocrosslinking or enzymatic cross-linking, along with temporal and spatial control of the cross-linking process, enables the manipulation of the GelMA-based bioink design and properties. This significantly improves the mechanical performance and shape fidelity of 3D-printed structures [ 99 , 100 ]. The GelMA bioink is often combined with photopolymerization-based bioprinting methods such that is rapidly solidify into finely structured microchannels with high shape fidelity in specific regions [ 101 ].
Collagen is an abundant component in animals and a primary component of connective tissue with a triple helix structure. Various types of collagens, including Types I, II, III, IV, and V, are used in tissue engineering research. Type I collagen is widely used in bioprinting because of its ability to self-assemble. However, Type I collagen cross-links slowly at 37 °C, which may result in insufficient structural stability in the later stages of bioprinting and lead to uneven cell distribution. In addition, the low viscosity and rapid degradation of pure collagen bioinks severely limit their application as "bioinks" in bioprinting tumor organoid models. Other compounds, such as alginate and hyaluronic acid, have been incorporated into collagen hydrogels to enhance viscosity, reduce degradation rate, and improve the printability of natural collagen.
Natural collagen molecules contain the same RGD peptide domain as gelatin [ 102 ], contributing to cell adhesion, proliferation, and differentiation. In addition, tumor-related modifications and remodeling of collagen proteins are key factors that enhance tumor invasion and metastasis [ 103 , 104 ]. Therefore, Type I collagen is typically used as an internal cell carrier. In contrast, compounds, such as alginate, are used as external support structures or combined with different polymers through extrusion to create consistent, high-throughput tumor organoid models [ 105 ].
HA is a polysaccharide present in organisms. As an important ECM component, hyaluronic acid possesses excellent rheological properties, biocompatibility, and biodegradability [ 106 ]. Furthermore, HA can promote cell proliferation and angiogenesis, mediate receptor interactions [ 107 ], and modulate cell behavior and function through physical or chemical cross-linking. These unique properties make it an ideal polymer for creating a 3D microenvironment that supports tumor cell growth. In addition, it is a lubricious hydrophilic polymer that can form highly viscous gels at low concentrations. It is commonly used as an additive to enhance the viscosity of gelatin and collagen-based bioinks, to maintain the stability of the printing structure.
However, the drawback of HA is its low shape fidelity during the bioprinting process. This can be addressed by utilizing photo-crosslinking-based bioprinting methods with methacrylate to form methacrylated hyaluronic acid (HAMA) [ 108 , 109 ], or further incorporating GelMA to form HAMA-GelMA "bioink" for constructing highly authentic vascularized tissues and neural networks [ 110 ].
PEG is a widely used biomaterial in the construction of biomimetic scaffolds in vitro [ 111 ]. PEG exhibits excellent mechanical properties, is non-cytotoxic within a specific molecular weight range, and is non-immunogenic as a biomaterial [ 112 ]. However, unlike natural polymers, PEG cannot form hydrogel structures with temperature variations or ionic cross-linking properties. In addition, PEG cannot promote cell adhesion and interaction. Therefore, PEG must be coupled with functional groups (such as methacrylates) or other functional polymer materials to achieve these cellular activities [ 113 ].
Polyethylene glycol diacrylate (PEGDA) is a polymer that undergoes copolymerization with acrylate. Compared with PEG, PEGDA possesses cross-linking properties, making it a biologically active material for preparing bioinks. Using photocrosslinking methods, PEGDA is commonly used to fabricate finely structured or controllable tumor models, such as lung tumors, glioblastomas, and multiple myelomas. Pluronic® F127 (PF127), composed of PEG and polypropylene glycol (PPG), is often used in extrusion-based bioprinting to serve as a sacrificial layer for observing the biological behavior of tumor cells by dissolving PF127 [ 114 ].
We have summarized and expanded upon the information regarding the advantages, disadvantages, and potential applications of the six bioinks in Table 2 for a more intuitive comparison.
Summary of the advantages, disadvantages, and applications of bioinks used in 3D bioprinting.
Benefit | Constraint | Applications | |
---|---|---|---|
, affecting the functionality and stability of the material. | |||
degradation: The degradation time of gelatin is sometimes too short, necessitating modification or the addition of crosslinking agents to adjust the degradation characteristics. | pH | ||
2.2.1. extrusion-based bioprinting.
Extrusion-based bioprinting is the most commonly used method whcih consists of three parts: a lifting platform, a nozzle, and an outlet structure [ 20 ]. With computer-assisted control, the mixed bioink is extruded from the nozzle under continuous squeezing pressure along the x-axis [ 115 ]. Simultaneously, the lifting platform moves along the y- and z-axes, depositing the material in a 2D pattern, sequentially stacking to form a 3D scaffold [ 116 ]. This method has a wide range of applications. It demonstrates good compatibility with biomaterials of different viscosities and cells of various concentrations and types [ 117 ], which enables the construction of tumor organoids with sufficient mechanical strength for building tumor microenvironments in hard tissues such as bone. Furthermore, it allows multiple nozzles to deposit different bioinks, which is suitable for constructing co-culture models to study the interactions between tumor cells and other cells. However, low resolution of hydrogel model is the key limitation of extrusion-based bioprinting [ 118 ]. The second limitation is the material nature of the bioink, which requires precise control of the nozzle temperature to prevent liquefaction and nozzle blockage, which can lead to material deformation and collapse [ 119 , 120 ] ( Fig. 2 A).
Schematic diagram illustrating the principle of tumor model formation based on extrusion-based and inkjet-based bioprinting methods with deposition of bioink. (A) Cellink 3D bioprinter. (B) Extrusion-based bioprinting method, and inkjet-based bioprinting method. Reproduced with permission [ 121 ]. Copyright 2021, Wiley-VCH. ( C ) By increasing the number of layers and decreasing the thickness, the resolution of the printed structure is improved, resulting in a tumor organoid model with a smooth surface appearance [ 122 ]. Reproduced with permission. Copyright 2018, Company Biologists.
Coaxial bioprinting is an extension of the extrusion-based printing method, where the coaxial circular structure of the nozzle has the advantage of simultaneously controlling the internal and external hierarchical structures, thereby enabling the printing of hollow tubular structures, particularly in the field of vascularization [ 123 , 124 ]. The core-shell structure allows the co-extrusion of two different bioinks, addressing the problem of insufficient mechanical strength of a single bioink and making the printing of tubular structures more convenient. The combination of extrusion-based bioprinting with sacrificial material can also be employed to construct functional vascular networks in tumor models, creating specifically shaped tumor models such as breast ductal carcinomas [ 50 ], vascularized tumor models, and microtumor microarrays [ 51 ]. This is crucial for revealing the close relationship between blood vessels and tumors including the interaction of circulating tumor cells with stromal and infiltrating immune cells, the exchange of secreted factors between different cells, the response to external stimuli, and the adaptive behavior of the tumor to the metastatic microenvironment [ 112 , 125 ].
Inkjet bioprinting is the first bioprinting technology and is a non-contact droplet-based bioprinter [ 126 ]. The inkjet printer consists of a liquid binder cartridge, a nozzle that moves along the x- and y-axes, and a platform along the z-axis. By electrically heating the nozzle head or inducing acoustic waves using piezoelectric crystals inside the print head [ 127 ], liquid droplets were ejected onto the substrate, adhering adjacent hydrogel inks together, forming a single layer of 2D patterns, subsequently lowering the layer and printing 3D structures layer by layer ( Fig. 2 B). By controlling the droplet size, deposition speed, and nozzle orientation, the bioink consisting of cells, scaffold material, and growth factors can be precisely deposited at high resolution (approximately 50 μm) and high printing speed (up to 10,000 drops per second) [ 128 ] ( Fig. 2 C). However, inkjet-printed models typically require long drying periods at high temperatures, which can lead to decreased utilization of bioinks. Similar to extrusion-based bioprinting, higher cell densities can lead to a high-viscosity of the bioink and nozzle clogging [ 129 ]; thus, only allowing the printing of low-viscosity bioinks. Additional crosslinking is required to ensure the stability of the printed structure [ 130 ].
Through inkjet printing, different types of cells and biomaterials can be printed at predetermined locations [ 18 , 122 ], simulating the complex structures and microenvironments of real tumor tissues such as osteosarcoma and ovarian tumors. This technology can also be customized according to the specific conditions of the patient, helping to simulate different types of tumor tissues better and providing more realistic and reliable in vitro models for drug development and treatment research.
Stereolithography can also be used to manufacture 3D printed models. It is based on the photopolymerization of photosensitive polymers [ 122 ]. Furthermore, the method uses light of specific wavelengths and intensities to scan from a point to a line focused on the surface of a liquid hydrogel in a container, resulting in a single layer of 2D cured patterns in the container. Subsequently, as the platform descends or rises to the designed single-layer thickness, the next layer continues to solidify using the abovementioned process to completely recover the previously generated 2D pattern with fresh bioink on the prefabricated structure until the 3D structure is completed [ 131 ]. Photolithography is not constrained by the viscosity of the bioink, which means that multiple bioinks with different viscosities can be used for printing, thereby enabling a more diverse range of applications for various biomaterials. Laser-assisted printing precents direct contact between dispensers and bioinks, enabling non-contact printing [ 132 ]. This method does not subject cells to mechanical stress, which is beneficial for maintaining cell viability, and provides the highest resolution among the three printing methods [ 133 ] ( Fig. 3 ).
Schematic diagram illustrating the principle of constructing organoid models using light-based bioprinting method. (A) Schematic representation of a liver organoid model constructed by light-based bioprinting. (B) Grayscale digital mask corresponding to the vascular structures of the liver lobules. (C, D) Images taken under fluorescence and bright field channels (5 × ) of fluorescently labeled hiPSC-HPC in GelMA [ 134 ]. Reproduced with permission. Copyright 2016, National Academy of Sciences.
Bioinks based on GelMA [ 135 ] and PEGDA [ 136 ] are commonly used in photolithography technology to create scaffolds with precise structures and controllable mechanical strength [ 137 ]. These scaffolds are subsequently used to simulate tumor tissues and provide valuable tools for oncology research. Scaffolds with precise structures and controllable mechanical strengths have been used in oncology research.
Laser-Induced Forward Transfer (LIFT) utilizes high-energy laser pulses to irradiate biological precursor materials, inducing instantaneous vaporization and gas formation, thereby transferring the biological precursor material from one substrate to another with rapid and precise micrometer or nanometer-level deposition. This technique is suitable for constructing intricate biological tissue structures and microscale biological chips. In the field of biomedicine, Laser-Induced Forward Transfer technology can be employed to build biomimetic tissue structures, biosensors, artificial bones, and provide essential tools for tissue engineering, drug development, disease diagnosis, and more [ 138 , 139 ].
The technology of volumetric bioprinting through tomographic scanning is an innovative approach that combines medical imaging techniques with 3D bioprinting. It leverages tomographic scanning (CT) or magnetic resonance imaging (MRI) to acquire three-dimensional biological structural information of specific parts of a patient's body, and then uses bioprinting to deposit or stack biological materials according to this model, enabling precise replication and reproduction of complex biological tissues. This technology can provide more personalized and customized solutions for tissue regeneration, transplantation, and disease treatment in the medical field. It holds potential for significant breakthroughs and innovations in medical research and treatment [ [140] , [141] , [142] ].
Electrospray bioprinting technology is an innovative method that utilizes the principle of electrospray to perform biological printing. The nozzle, loaded with bio-ink or cell suspension, is activated by a high electric field voltage, creating tiny sprayed droplets. These droplets then deposit onto a substrate in a controlled manner, forming the desired biological tissue structure. Electrospray bioprinting can be used to construct complex biological tissue engineering structures, such as neural tissues, vascular networks, and more. Additionally, it can be applied in areas like cell microarray preparation, biosensor manufacturing, and beyond. However, constraints such as the viscosity of biological materials and surface tension need further research and optimization before clinical application [ 143 , 144 ].
Plasma-enhanced bioprinting is a method that combines plasma technology with bioprinting technology. In this technique, plasma is used to modify the chemical properties of biological materials such as extracellular matrix and hyaluronic acid, altering factors like crosslinking degree and surface charge to enhance adhesion, biocompatibility, and mechanical performance. By activating the surface of printing substrates or support materials, enhancing their wettability and affinity, it promotes cell and biomaterial adhesion, thereby improving the success rate and forming quality of bioprinting. This method strengthens and optimizes the bioprinting process, showcasing innovation and cutting-edge advancements [ 145 ].
Magnetic-assisted printing technology is an advanced printing method that utilizes magnetic materials and an external magnetic field to assist in positioning and printing. It typically involves introducing magnetic particles or magnetic liquid into the printing material or support structures, and controlling the positioning and shape of these magnetic components by applying an external magnetic field. The magnetic stimulation can help overcome factors such as gravity and surface tension, induce the oriented alignment of cells, activate cell signaling pathways, enhance cell proliferation and differentiation, and achieve a flexible, efficient, and controllable printing process. Magnetic-assisted 3D bioprinting technology has brought new breakthroughs to tissue regeneration and organ repair in the biomedical field, offering new possibilities and development opportunities [ 146 , 147 ].
Acoustic bioprinting technology utilizes sound waves as a driving force to achieve precise positioning and organization of bio-materials. By using special piezoelectric elements or acoustic lenses to convert electrical signals into high-frequency sound waves and focusing them on specific areas, a high-energy density sound wave beam is formed. This beam can generate thrust and tension on bio-materials, avoiding mechanical damage to cells, while achieving precise positioning and arrangement of cells, bio-inks, or other biological components with a resolution down to the micrometer or even submicron level. The accuracy, efficiency, and controllability of acoustic bioprinting technology contribute significantly to innovation in the fields of tissue engineering and regenerative medicine in the biomedical field [ [148] , [149] , [150] ].
3.1. breast tumor organoid bioprinting.
Breast tumors are among the most common tumors in women and a leading cause of female mortality [ 151 ]. Breast tumors are characterized by the uncontrolled proliferation of breast epithelial cells in response to various carcinogenic factors. Symptoms such as breast lumps, nipple discharge, and axillary lymphadenopathy occur in the early stages of the disease. In the late stages, distant metastasis of tumor cells may lead to multi-organ damage, directly threatening the patient's life. Breast tissue has a unique structure comprising mammary glands (lobules and ducts) and adipose tissue [ 152 ]. The tumor microenvironment plays a crucial role in tumor progression. Traditional 2D in vitro cell cultures lack spatial heterogeneity and exhibit overly simple structures [ 153 ]. Establishing physiologically relevant in vitro tumor models through bioprinting, including interactions between tumor cells and the extracellular matrix of the breast microenvironment, as well as simulating hollow ductal channels of the mammary gland, is essential for a better understanding of the biological behavior of tumor cells in a natural breast tumor microenvironment [ 154 ].
Invasive proliferation and migration are key features of tumors in vivo . Tumor cell metastasis is significantly influenced by the biophysical properties of the tumor microenvironment. The stiffness of in vitro biomimetic organoid models is one of key issues that influences the behavior of tumor cells. GELMA hydrogel is a photosensitive hydrogel that has proven to be a candidate material for basic biological research [ 155 ] and is used to construct biologically relevant tissue structures. In an organoid tumor model constructed using photolithography Nitish et al. [ 45 ] observed that MDAMB231 cells moved slowly and maintained stable migration in the central region with high hardness (748 ± 90 Pa) based on the photosensitive properties of GELMA. In contrast, the opposite behavior is observed in the surrounding region with low hardness (313 ± 89 Pa). Similarly, the alginate-gelatin composite bioink with low hardness (A1G5 and A1G7) facilitated the formation of tumor spheroids and the migration of tumor cells in a 3D environment. Conversely, materials with high hardness (A3Gy and A5Gy) inhibited the formation of tumor spheroids [ 49 ]. Therefore, the stiffness of ECM can significantly influence biological behaviors such as tumor cell migration, invasion, and metastatic potential, providing new strategies and targets for tumor treatment and prevention, which warrants further in-depth research and exploration. By adding Matrigel, iterative culturing of MDAMB231 tumor spheroids was achieved in the AxGyMz composite bioink [ 53 ]. Matrigel is the basement membrane (BM) extract most commonly used for 3D organoid cultures. Matrigel is the most commonly used basement membrane (BM) extract for three-dimensional organoid culture, but it is extracted from mouse tumors and cannot fully replicate the specific microenvironment of human tumors. Additionally, the composition and mechanical properties of Matrigel vary between batches, affecting the reproducibility of experiments. In a composite bioink of 5 % GelMA +0.5 % collagen, MDAMB231 exhibited similar invasive behavior to that of Matrigel, suggesting that this stiffness-adjustable, cost-effective, and novel hydrogel has potential as an alternative to Matrigel [ 51 ]. Researching new hydrogel materials as alternatives to Matrigel is of great significance. It helps improve and optimize the performance of materials, broaden the functional range of materials, achieve consistency between batches, and further drive innovation and advancement in tissue engineering and disease modeling technologies. However, MDAMB231 cells exhibited the opposite biological behavior in the novel PEG-4MAL bioink, which has highly tunable mechanical and biological functional properties. Compared to softer hydrogel systems (0.7 kPa + RGD), significant migratory behavior was observed in MDAMB231 cells within the harder hydrogel (1.1 kPa + RGD), likely because of the modification with cell adhesion peptide (RGD) [ 55 ]. Similarly, interaction with RGD promotes the migration of MCF-7 cells [ 50 ]. Therefore, future research should focus on precisely controlling the stiffness factor of the tumor microenvironment by adding different extracellular matrix components in hydrogel systems, including temporal and spatial control. Multi-level, multi-component hydrogel structures can help researchers better understand how tumor cells respond to different mechanical microenvironments, potentially providing new perspectives and methods for revealing the mechanisms of tumor initiation and development. This could contribute to the development of more effective strategies for tumor treatment and prevention. In recent years, bioprinting using dynamically cross-linked hydrogel networks has attracted significant attention because they can better mimic the mechanical properties of the ECM and respond to biological stimuli. A dual cross-linked dynamic hydrogel network based on the boronic acid motifs of laminarin (LAM-PBA) and alginate exhibited excellent cell compatibility (cell viability exceeded 90 %). By controlling the cross-linking process of both types, the processability, mechanical behavior, and stability of the bioink can be further improved [ 52 ]. This study ingeniously combines dynamic covalent crosslinking and ion crosslinking to form a double network structure, providing a new tool and perspective for the field of tissue engineering. However, detailed mechanical property data of this double network structure bioink, such as tensile strength and modulus, were not provided in the study. These data are crucial for evaluating the performance of the bioink in the 3D printing process and for further optimizing the material formulation.
Interactions among tumor, immune, and mesenchymal cells within the tumor microenvironment significantly affect tumor growth and behavior. Understanding these interactions is crucial for a deeper comprehension of breast tumor cellular characteristics and behavioral changes. In breast tumors, adipocytes are important agents that play roles in promoting tumor progression within the tumor microenvironment. They can induce inflammatory responses, influence the metabolic reprogramming of tumor cells, and provide the necessary nutrients and growth signals for tumor growth and dissemination. Hence, understanding the regulatory role of adipocytes in the breast tumor microenvironment helps deepen our understanding of the pathogenic mechanisms of breast tumors [ 156 ]. Hannes et al. [ 54 ] constructed a co-culture model of adipose tissue with breast tumor cells. After nine days of co-culturing, they observed that tumor cells induced a decrease in the lipid content of the adipose tissue and remodeling of the extracellular matrix (with a significant increase in the expression of collagens I, VI and fibronectin). This integrated 3D breast cancer-adipose tissue model illustrated the pro-tumorigenic effects of the adipose in breast cancer. In the future, the introduction of other key cell types such as immune cells, vascular endothelial cells, etc., can further elucidate the specific regulatory roles of factors secreted by adipose cells in tumor development. The bone is one of the most common sites of metastasis in advanced breast tumors [ 157 ]. To better understand bone metastasis in breast tumors, a bionic bone-specific microenvironment was created by incorporating hydroxyapatite-containing nanoparticles into a PEG/PEGDA hydrogel, the presence of MSC increased the number of MDAMB231 cell spheroids compared to culturing tumor cells alone [ 47 ]. Similarly, in a co-culture of osteoblasts with MDAMB231 cells, osteoblasts promoted tumor cell proliferation and tumor sphere formation, whereas MDAMB231 cells inhibited osteoblast proliferation [ 46 ]. Overall, the addition of helper cells enhanced the bionic nature of the tumor model, which is more valuable in studying the interactions of the tumor microenvironment. In the future, it may be considered to incorporate other cell types, such as inflammatory cells, to comprehensively simulate the impact of multiple factors on bone metastasis. Alternatively, integrating the 3D printing model with clinical case data for comparison of research outcomes with actual patient conditions can provide better validation of experimental results.
Resistance to anti-tumor drugs is another important characteristic of malignant tumors [ 64 ]. Using bioprinting in vitro organoid tumor models can prevent the false positive behavior of tumor cells exposed to anti-tumor drugs in 2D cultures. Therefore, bioprinting in vitro organoid tumor models can serve as a better preclinical platform for drug screening and personalized drug development. Song et al. [ 57 ] successfully maintained the growth of drug-resistant MCF-7 breast tumor spheroids in a gelatin-sodium alginate hydrogel, preserving the CD44 high/CD24 low/ALDH1 high phenotype ( Fig. 4 ). At the same time, the EC50 values for apoptosis and necrosis concurrently induced by PTX in the resistant spheroids were 124 nM and 131 nM, respectively. In contrast, the EC50 values for PTX-induced apoptotic and necrotic cell death in larger spheroids were 59 nM and 54 nM, respectively. In the same year, the team further achieved a novel in situ assessment of the efficacy of PDT on tumor spheroids, with significantly higher IC50 values for the photosensitizers sTPP and Ce6 in 3D spheroids than in 2D cultures (7-fold difference) at the same radiant power. Interestingly, heterogeneous responses of individual tumor cells within a single tumor sphere to photodynamic therapy were observed suing 3D imaging. Furthermore, individual drug-resistant cells within the spheres were suggested to be responsible for the emergence of drug resistance in the tumor spheres. However, the main shortcoming of these experiments is the lack of in-depth research on the mechanisms of PDT. The analysis was conducted merely from the perspective of overall cell death. In the next step, other cell death detection methods (such as apoptosis markers and cell cycle analysis) could be combined to further explore the mechanisms of cell death induced by PDT. Similarly, in other experiments inducing tumor apoptosis with PDT, 3D tumor spheroids overexpressed the ABCG2 transporter protein, which expelled an excess of the photosensitizer PPIX from the tumor cells, thereby reducing the therapeutic effect of PDT compared to 2D models [ 158 ]. Unfortunately, this experiment did not compare the genetic changes in in vivo tumor models with 3D spheroids, making it unable to further demonstrate the persuasiveness of the 3D tumor model. Similarly, upon establishing a 3D culture model with a spontaneously generated hypoxia and drug resistance central core, the generation of the central core in tumors may be one of the most critical factors limiting the effectiveness of PDT in clinical practice [ 159 ]. 3D models provide a visual representation of the interaction between tumor spheroids and drugs in vitro . This demonstrates the ability of 3D models to effectively mimic the tumor microenvironment in vivo , which is crucial for understanding the response to PDT treatment and the process of hypoxic core formation [ 56 ]. In the future, patient-derived tumor cells or organ samples can be extracted for model construction with high clinical relevance to reflect the response of tumors in patients to PDT. Additionally, by combining higher resolution imaging techniques (such as multiphoton microscopy) to monitor microenvironmental oxygen levels and metabolic changes, in-depth research on the mechanism of action of PDT can be conducted.
Schematic representation of the construction of breast cancer organoid models for drug screening using bioprinting. (A) Confocal microscopy images showing the expression of CD44, ALDH1, and CD24 in drug-resistant spheroids. (B) Methodology for quantitative cell viability measurement in embedded MCF-7 spheroids. 3D spheroid images based on their respective intensity profiles under white light and fluorescent modes for 7-AAD [ 57 ]. Reproduced with permission. Copyright 2022, Elsevier.
Glioblastomas, or gliomas, are the most common primary malignant tumors of the central nervous system in adults [ 160 ]. Owing to its high malignancy rate, rapid progression, and diffuse infiltration, glioblastomas typically cannot be completely removed through surgery and tend to recur after surgery [ 161 ]. In addition, glioblastomas exist within a complex tumor microenvironment (TME) containing various cell types, including glioblastoma cells, glioblastoma stem cells (GSCs), mesenchymal stem cells (MSCs), and immune cells [ 162 ]. In addition, there are differences in cell characteristics and gene expression patterns in different regions. Traditional 2D cultures cannot simulate cell interactions and tumor microenvironment interactions. Therefore, studies of glioblastomas are limited. Bioprinting has facilitated the construction of clinically relevant brain tissue organoid models, by accurately placing tumor cells to replicate the natural tumor microenvironment. It is becoming a promising tool for creating simulated GBM structures and cell compositions and studying tumor biology.
In recent years, various laboratories have advanced the bioprinting of glioblastoma models by developing new bioprinting methods, leading to in-depth research on in vitro glioblastoma models. Shu et al. [ 58 ] first constructed a U87MG glioblastoma model on a sodium alginate hydrogel using extrusion bioprinting. After 11 days of printing, the cell viability remained at 88 ± 4.3 %. By utilizing photolithography and adjusting the shape of the PEGDA microcavities, they further controlled the shape, size, and thickness of U87MG glioma spheroids [ 59 ]. Similarly, in a bioink composed of fibronectin, alginate, and laminin, U87MG formed tumor spheroids, with high CD133 and DCX expression, indicating the maintenance of glioblastoma stem cell-like characteristics [ 62 ]. Erin et al. [ 66 ] utilized an immersion bioprinting method to construct a high-throughput in vitro glioblastoma organoid model using patient-derived tumor cells in a 96-well plate. This technology retains the heterogeneity of patient-derived tumors but requires further research to improve and expand the consistency of patient tumor organoids (PTOs). Further optimize 3D printing techniques to enhance the stability and complexity of tumor organoids, better simulating the biological characteristics of primary tumors. This high-throughput modeling method can be combined with artificial intelligence technology to achieve a more intelligent process for tumor organoid construction and drug screening. Interestingly, Matteo et al. [ 67 ] utilized FRESH 3D bioprinting to construct a glioblastoma organoid model of human neuroblastoma (SH-SY5Y cell line) using conductive bioink based on cellulose nanofibers (CNF), alginate, and single-walled carbon nanotubes (SWCNTs). This model promotes the mature differentiation of SH-SY5Y cells into mature neurons and facilitates the formation of neural networks ( Fig. 5 A). Furthermore, this innovative experiment provides a tool for better understanding the pathophysiological mechanisms of brain tumor-related neurological disorders. However, this study did not delve into the mechanisms by which the conductive nanocellulose scaffold induces neuroblastoma cell differentiation. Future works are suggested to focus on attempting to implant the scaffold into animal models for in vivo validation to observe its impact on neural function restoration, thereby assessing its feasibility for clinical applications. Combined with high-throughput technologies such as transcriptomics and proteomics, a systematic analysis of the molecular mechanisms by which the scaffold promotes neuroblastoma cell differentiation can provide a deeper theoretical foundation for related drug development.
Schematic representation of the construction of a glioma organoid model using bioprinting. (A) Workflow of FRESH bioprinting technology and brain-like scaffolds obtained by bioprinting with cellulose-based bioinks [ 67 ]. Reproduced with permission. Copyright 2020, MDPI. (B) Schematic representation of the bioprinting process and bioprinting mini-brains, as well as a schematic representation of the crosstalk between glioblastoma cells and macrophages [ 64 ]. Reproduced with permission. Copyright 2019, Wiley-VCH.
Glioblastoma is an intracranial tumor with a poor prognosis, characterized by an extensive abnormal vascular network. Furthermore, glioblastomas often use the microvasculature to guide migration. Understanding the cellular interactions between vascular and GBM cells may lead to new therapeutic strategies. By co-culturing primary adipose-derived stem cells with human umbilical vein endothelial cells (HUVECs) in a composite hydrogel of 5 % GelMA and 2.5 mg ml−1 fibronectin at a ratio of 1:0.75, a successful simulation of a vascularized tumor microenvironment was achieved. Patient-derived STA-NB1 neuroblastomas attract microvessels to approach and migrate within them [ 69 ]. To further explore the angiogenic potential of glioma cells, an in vitro model using neuroglioma U118 cells and glioma stem cells GSC23 cells was established. Both 3D-U118 and 3D-GSC23 cells demonstrated the ability to form blood vessels. 3D-GSC23 cells exhibit strong capabilities to form cell spheroids, secret VEGFA, and form tubular structures in vitro [ 65 ]. In summary, the experimental results above suggest that the glioma microenvironment model exerts a promoting effect on the vascularization process of glioma cells. Glioma cells can stimulate the proliferation of endothelial cells and the formation of luminal structures, thereby promoting the growth and dissemination of gliomas. Xu et al. conducted a series of studies on glioma stem cells. Firstly, they successfully enriched glioma stem cells using a gelatin-alginate-fibrinogen (GAF) hydrogel scaffold, and the enriched glioma stem cells retained the inherent characteristics of tumor stem cells [ 63 ]. They also showed the potential to differentiate into glial, neuronal, and vascular endothelial cells [ 60 ]. To observe the crosstalk between tumor microenvironment cells, glioma stem cells (GSC) and mesenchymal stem cells (MSC) were co-cultured using coaxial bioprinting. The interactions between GSC and MSC and their roles in tumor progression were observed. The results showed that GSC and MSC fused, and the fused cells co-expressed biological markers of both GSCs and MSCs, and exhibited stronger proliferation, clonogenicity, and invasive capabilities than GSCs and MSCs. Furthermore, the fused cells showed stronger tumorigenicity in nude mice, exhibiting pathological features of malignant tumors [ 61 , 68 ]. This cell fusion may be an important mechanism leading to the poor prognosis of gliomas. The newly formed hybrid cell lines resulting from cell fusion exhibit more aggressive and hypoxia-tolerant malignant phenotypes, providing insights into further understanding tumor heterogeneity and treatment resistance. Blocking cell fusion or disrupting the key signaling pathways of fused cells could potentially become a new therapeutic strategy. Similarly, during co-culture with glioblastoma cells, glioma-associated macrophages (GAM) are recruited by glioma cells and polarized into a GAM-specific phenotype. They actively secreted growth factors to promote tumor cell proliferation [ 64 ] ( Fig. 5 B). Therefore, by disrupting the interactions between glioma cells and GAMs, or altering the polarization state of GAMs, an important strategy for future glioblastoma treatment may be developed.
Lung tumors originate from the bronchial mucosa or glands in the lungs. Lung tumors are one of the most common and deadliest malignant tumors worldwide, posing a significant problem health issue and a substantial burden [ 163 ]. The treatment options for lung tumors include surgery, radiation therapy, chemotherapy, and targeted drug therapy. The development of drug resistance often contributes to the recurrence of lung tumors, as lung tumor cells have demonstrated the ability to develop resistance to chemotherapy [ 163 , 164 ]. In addition, the tumor microenvironment plays a crucial role in drug resistance. Inflammatory cells and factors within the tumor inflammatory microenvironment promote tumor angiogenesis, epithelial-mesenchymal transition, cell apoptosis, and the activation of inflammatory pathways, leading to the occurrence, development, metastasis, and drug resistance of lung tumors [ 165 , 166 ]. Moreover, most studies on tumor occurrence, progression, and the assessment of anti-tumor drugs are based on 2D tumor models, which may lead to the loss or alteration of some original features and functions. Bioprinting offers a reliable, biomimetic 3D tumor model replicating the actual in vivo environment, aiding in the study of tumor development and drug screening.
Gelatin-alginate hydrogels are commonly used to construct in vitro models of lung tumors by simulating the in vivo tumor microenvironment (TME) to aid in the study of tumor growth, invasion, and drug screening. Xu et al. [ 70 ] maintained continuous proliferation of A549 cells in gelatin-alginate hydrogels for up to 28 days. Arindam et al. [ 71 ] observed upregulation of vimentin, α-SMA, and loss of E-cadherin during co-culturing of non-small cell lung tumor (NSCLC) patient-derived xenograft (PDX) cells and lung CAFs, confirming the feasibility of using gelatin-alginate hydrogel for studying cell-cell crosstalk. Furthermore, drug sensitivity testing of eight traditional anti-tumor Chinese medicines showed that, compared to 2D models, 3D models exhibited higher drug resistance [ 73 ]. This validates the practicality of using a gelatin-sodium alginate hydrogel as a 3D bioprinting lung organoid tumor model for drug screening.
In recent years, the emergence of many novel composite bio-inks has deepened our understanding of lung tumor organoid models. By printing the Hphil-CNF hydrogel on the surface of the Hphob-CNF hydrogel, hollow 3D channels were formed, allowing the real-time observation of cell morphology, cellular responses to drug stimuli, and chemical flow within the channels [ 72 ]. It provides an innovative and promising experimental platform for cell culture and biomedical research. Similarly, in GelMA-PEGDA hydrogels, the high upregulation of lung CSC-specific marker genes indicates that this model promotes the expression of lung CSC-specific markers in non-small cell lung tumor (NSCLC) cells [ 75 ]. It revealed the biological behavior of lung cancer stem cells under different conditions. Likewise, patient-derived NSCLC cells form 3D spheroids in the polysaccharide-based ink H4-RGD, showing stronger resistance than 2D monolayer cells to NSCLCPDX cells [ 74 ]. This suggests a role for the tumor microenvironment created by Ink H4-RGD in determining the variability of chemotherapeutic responses in three-dimensional spheroids.
Cervical tumors are the most common malignant tumors of the female reproductive tract, and human papillomavirus (HPV) is a primary risk factor for the development of this disease [ 167 ]. Early cervical tumors often have no obvious symptoms or signs, and in advanced stages, they can present with systemic symptoms such as anemia and cachexia. Furthermore, early-stage cervical tumors are prone to lymphatic metastasis, leading to a relatively poor prognosis, while late-stage metastasis results in poor prognosis and a high mortality rate [ 168 ]. However, the potential mechanisms underlying metastasis remain unclear [ 169 ]. Therefore, establishing biologically relevant organoid models to elucidate the mechanisms of cervical tumor cell migration and invasion is crucial for providing a platform for in vitro mechanistic studies and personalized treatment of HPV-related cervical diseases [ 170 ].
Chen et al. [ 76 ] used photolithography-based bioprinting technology to construct a 3D in vitro microchip with a honeycomb-like branched blood vessel structure in a PEGDA hydrogel. The migration speed of HeLa cells increased as the width of the microvascular channels decreased, revealing a close correlation between tumor cell migration and blood vessel diameter. Although this 3D model provides a rapid and cost-effective tool for studying tumor migration, it does not elucidate the mechanisms of tumor cell migration. To further investigate the crucial stage of epithelial-mesenchymal transition (EMT) in cervical tumor cell metastasis, Sun et al. added the main inducer of EMT, TGF-β [ 171 , 172 ]. They observed the disintegration of 3D HeLa cell spheroids formed in collagen-sodium alginate-Matrigel, with immunohistochemistry showing activation of the Smad2/3 pathway, promotion of the transcription factor Snail, and suppression of E-cadherin, indicating achievement of the EMT process [ 77 ]. By further combining gene editing technologies (such as CRISPR-Cas9) and single-cell RNA sequencing, it is possible to study in greater detail the changes in gene expression and signaling pathways during the TGF-β-induced EMT process. Therefore, establishing an effective environmental stimulus as a regulatory sign in a 3D tumor model can help us better understand the occurrence and development of cervical tumors and subsequently regulate tumor metastasis by modulating the tumor microenvironment. Overall, this study provides new methodological tools for EMT research in cervical cancer, which is of significant importance. Further optimization and application of this model are expected to bring more discoveries regarding EMT and tumor progression mechanisms.
Among all gynecological malignancies, ovarian tumors have the highest mortality rate [ 173 ]. Early ovarian tumors lack symptoms, and when symptoms appear, they are nonspecific, leading to a poor overall prognosis and propensity for metastasis and recurrence [ 174 ]. Traditional 2D cell culture systems have led to significant medical advancements in oncology research; however, the progression of ovarian tumors remains unclear. Organoid models constructed based on bioprinting can recreate the unique glandular structure of ovarian tissue in vitro and, through temporal and spatial control of the tumor microenvironment, simulate the interactions between different cell types in a high-throughput and reproducible manner. This allows for a systematic study of the various unknown regulatory feedback mechanisms between tumor and stromal cells and provides a tool for researching tumor biology [ 175 , 176 ].
Fibroblasts play a crucial role in the malignant progression of ovarian tumors [ 175 ]. An in vitro ovarian tumor model was constructed by co-culturing OVCAR-5 cells and MRC-5 cells on Matrigel™. Through the use of a 150 μm micro-nozzle, precise cell positioning and assembly were achieved, and it was observed that tumor cells spontaneously formed glandular structures resembling ovarian tumor micro-nodules in vivo . Where tumor cells spontaneously formed glandular structures resembling micro-nodules of ovarian tumor in vivo [ 79 ]. In future studies, various stromal cells could be introduced into this 3D ovarian tumor in vitro model to systematically study many unknown regulatory feedback mechanisms between cells, facilitating high-throughput drug screening and therapeutic interventions.
Intrahepatic cholangiocarcinoma (ICC) cells are the second most common primary liver tumor cells within the liver [ 177 ]. The incidence and prevalence of ICC have been increasing every decade, and most patients with ICC present with advanced or refractory metastatic disease [ 178 ]. Moreover, treatment options for ICC are limited, with only approximately 20–30 % of patients qualifying for surgical resection, which is considered the only potentially curative treatment [ 179 ]. However, drug therapy has shown limited effectiveness. Mouse models are a crucial tool for drug screening in ICC, but they are associated with ethical controversies, time-consuming processes, high costs, and complex operations [ 180 , 181 ]. The bioprinted ICC tumor model exhibits higher resistance to anti-tumor drugs than 2D cultures, highlighting the potential role of patient-derived tumor models created through bioprinting in oncology research and the development of personalized treatments.
Patient-derived ICC cells are likely to have more clinical significance compared to ICC cell lines, as the cell lines have already lost their heterogeneity. Mao et al. [ 78 ] employed patient-derived primary ICC cells in a gelatin-alginate-MatrigelTM composite hydrogel system to construct an in vitro tumor model. Compared to 2D culture, the tumor markers CA19-9 and CEA, cancer stem cell markers CD133 and EpCAM, and liver damage-related liver function markers ALT, AST, and ALB were upregulated by 1.9, 5.7, 3.7, 9.7, 3.7, 1.9, and 2.0 times, respectively, in 3D bioprinting models. Therefore, the 3D in vitro culture model can more accurately mimic in vivo tumor phenotypes and thus can more precisely simulate treatment responses.
Osteosarcoma is the most common primary malignant bone tumor in adolescents [ 182 ], characterized by the direct production of bone-like tissue from tumor cells. The development of drug resistance and metastasis is closely associated with poor prognosis. In addition, the osteosarcoma microenvironment is now recognized as essential for its growth and spread [ 183 ]. To identify new therapeutic targets, a better understanding of the mechanisms underlying tumor drug resistance and metastasis is urgently needed. Therefore, it is crucial to elucidate the interactions between osteosarcoma cells and the complex bone and bone marrow microenvironments [ 184 ]. Bioprinting technology can manufacture novel bone tissue engineering scaffolds with customized shapes [ 185 ], mechanical strength, and cellular composition, providing accurate in vitro migration and drug screening experiments [ 186 ].
Pellegrini et al. [ 82 ] constructed a 3D in vitro osteosarcoma model by embedding U2-OS cells and their drug-resistant strain U–2OS/CDDP 1 μg in collagen hydrogel. The cells grew uniformly within the scaffold, and the tumor cell clusters degraded the collagen matrix, creating lacunae through which they migrated, similar to acellular scaffolds. This invasion behavior is akin to that of tumors in vivo . This osteosarcoma model successfully maintained the biological characteristics of OS cells in their natural microenvironment, making it a promising tool for drug screening and OS cell biology research.
Melanoma is one of the most aggressive and progressive forms of skin tumor [ 187 ]. It primarily occurs in the skin but can also develop in various locations and tissues such as the mucous membranes and meninges. As the disease progresses, melanoma exhibits regional and distant metastases, leading to a poor prognosis, with a 5-year survival rate of less than 5 %. Although several new drugs have been developed in recent years, most patients do not show a lasting response to these treatments [ 188 ]. Therefore, new biomarkers and drug targets are required to improve the accuracy of melanoma diagnosis and treatment [ 189 ]. 3D bioprinting based on in vitro cell culture is a novel and creative method for creating a simulated microenvironment for the growth of malignant melanoma cells that mimics the human body environment.
A 3D scaffold composed of GelMA-PEGDA composite hydrogel was fabricated to construct an in vitro tumor model simulating the growth microenvironment of human malignant melanoma cells (A375) [ 80 ]. The melanoma cells on the 3D scaffold exhibited higher proliferation rates, elevated MMP-9 secretion levels, and increased invasiveness compared to those in a 2D environment. Conducting longer-term cultivation experiments to observe the long-term behavior of tumor cells within the scaffold could further advance this technology's application in cancer research and drug development.
Multiple myeloma (MM) is a malignant proliferative disease of plasma cells that accounts for approximately 12 % of malignant tumors of the hematopoietic system. A characteristic feature of this disease is the uncontrolled proliferation of plasma cells in the bone marrow, leading to organ or tissue damage [ 190 ]. MM is characterized by the following four main features: bone destruction, renal dysfunction, hypercalcemia, and anemia. MM occurs almost exclusively within the bone marrow microenvironment, which provides the necessary signals and stimuli to induce cell proliferation and/or prevent apoptosis, promoting the development of drug resistance [ 191 ]. Therefore, reproducing the specific bone marrow microenvironment of MM cells is crucial for understanding the molecular mechanisms driving MM progression and treatment
resistance ( Fig. 6 ).
Schematic representation of an osteosarcoma organoid model constructed using coaxial bioprinting. (A) Schematic of the coaxial nozzle used for bioprinting. MM cells filled with a low concentration of GelMA represent the inner core of the cartilage marrow, the sheath used to mimic the surrounding cortical bone. (B) The inner/outer diameter of bioprinting nucleus-sheath structures positively correlates to the supply rate of core bioinks [ 81 ]. Reproduced with permission. Copyright 2022, Wiley.
Using coaxial bioprinting, a composite bioink simulating the outer cortical bone composed of GelMA, alginate, PEGDA, and nHA, as well as the inner bone marrow-like microenvironment composed of GelMA and MM cells, was printed simultaneously to mimic the human bone marrow niche [ 81 ]. With this method, a 3D core-sheath model was employed for the first time to achieve co-culturing of MM and HS-5 stromal cells. Moreover, it was observed that IL-6 secreted by HS-5 promotes the proliferation and aggregation of MM cells, demonstrating this co-culture model held significant implications for guiding combination drug therapy in tumors.
Chronic lymphocytic leukemia (CLL) is a complex and heterogeneous hematologic malignancy of the blood system [ 192 ], and it is the most common adult leukemia in Western countries [ 193 ]. Studies have shown that CLL pathogenesis is closely related to the tumor-supportive microenvironment and immune system dysfunction. The disease exhibits significant clinical variability and remains incurable [ 194 , 195 ]. In addition, culturing primary CLL cells in vitro is challenging, and traditional two-dimensional in vitro models lack the cellular and spatial complexity present in vivo , leading to an incomplete understanding of the actual events occurring at these sites. Francesca et al. [ 83 ] established the first long-term 3D culture model for CLL by embedding CLL cells in a fibronectin 411 hydrogel matrix, maintaining the growth of primary CLL cells for up to 28 days while preserving the expression of the characteristic surface markers CD19 and CD5. This represents a groundbreaking advancement and provides a reference for simulating the physiological settings of other non-solid tumors ( Fig. 7 ).
Schematic representation of the construction of a chronic leukemia organoid model using bioprinting. (A) Schematic representation of the bioprinting strategy using the CLL cell line MEC1 or CLL primary B cells. (B, a) Representative H&E staining of 5 μm cryosections of 3D bioprinting CLL progenitor cells showing their distribution in the scaffold. (B, b) Representative images of bioprinting CLL progenitor cells acquired using Axio Observer Zeiss fluorescence microscopy for live/dead assay at day 28 [ 83 ]. Reproduced with permission Copyright 2021, Frontiers Media.
This study detailed the construction of in vitro organoid tumor models using various bioinks combined with different printing methods. The emergence of 3D bioprinting technology has led to significant breakthroughs in developing various in vitro organoid tumor models and hydrogel tissue engineering. Using bioprinting technology, significant technological innovations have been achieved in material selection and overall construction. Multiple printing techniques and bio-materials are being used to address the limitations of traditional tumor organoid modeling. In vitro organoid tumor models modify the heterogeneity of the microenvironment, including the presence of non-tumor cells and their functions, the signaling of soluble cell factors, and changes in extracellular matrix components.
Tumor treatments are increasingly shifting towards personalized therapies targeting individuals with unique and heterogeneous diseases. Some studies have linked in vitro model responses to drugs with patient outcomes. The use of in vitro models for high-throughput drug screening is widely applied in oncology research and holds promise as a potential tool for screening effective drugs for patients with tumors. The main limitations of functional precision medicine are the establishment of physiological culture models, the development of high-throughput systems, and difficulties in measuring tumor heterogeneity. Bioprinting overcomes these barriers, with 3D in vitro tumor models being promising for precision medicine, allowing for rapid in vitro modeling using tumor cells sourced from patients to accurately simulate patient responses to treatment. They are physiologically relevant, personalized tumor models that are highly suitable for drug development and clinical applications and facilitate individual tumor response analysis.
Although bioprinting organoid tumor models are continuously advancing and providing innovative biomedical and clinical translational research approaches, some obstacles remain to be addressed. First, current tumor models only simulate a single type of tumor and cannot simultaneously simulate the development of multiple tumors. In the future, the various advantages of bioprinting will make it suitable for developing human tumor microchip models, and microchip technology is expected to achieve connectivity and communication between multiple tumor models, treating various organs/tissues as one model. Using this multi-organ microchip model, complex drug metabolism that single-organ tumor models cannot simulate can be achieved, similar to the human body environment.
Second, limited reproducibility is a significant barrier to generating organoid tumor models and maintaining their functionality. The primary factors affecting the reproducibility of tumor models include batch-to-batch variability, production scalability, cell composition, and tumor model structure. Future material research should focus on developing and designing bioinks with better biological performance or composite bioactive factors to functionalize bioinks continually, thus mimicking in vivo growth factors or other mechanical and chemical stimuli to functionalize and maintain the reproducibility of printed structures. By improving the standards of bioprinting materials, the reproducibility of tumor models will continue to improve, ultimately leading to significant progress in clinical trials.
Further expansion of bioprinting technology is needed to elucidate the interactions between multiple cells and build organoid tumor models that better reflect physiological states, thereby increasing their usefulness in clinical trials. Meanwhile, 4D printing, a promising technology platform with highly tunable material selection, allows bio-materials to respond to external stimuli, enabling the development of bio-folding hydrogel scaffolds with self-folding behavior and allowing pre-printed 3D configurations to change over time, advancing the manufacture of functional 3D tissues significantly. 4D printing technology is also attractive for drug delivery systems, allowing the programmable release of drugs or cells, reducing drug leakage, and improving drug delivery efficiency. So far, existing self-assembly or self-folding 4D printing systems have been limited to macroscopic deformations, restricting the precise spatial manipulation of 4D printed structures. Therefore, the exact construction of organoid tumor models requires the integration of advanced technologies from various fields.
Xiangran Cui: Writing – original draft, Visualization, Validation, Resources, Methodology, Formal analysis. Jianhang Jiao: Validation, Resources, Methodology, Funding acquisition. Lili Yang: Writing – review & editing, Validation, Resources. Yang Wang: Writing – review & editing, Supervision. Weibo Jiang: Writing – review & editing, Supervision. Tong Yu: Writing – review & editing, Validation, Resources. Mufeng Li: Writing – review & editing, Supervision. Han Zhang: Writing – review & editing, Validation, Resources. Bo Chao: Writing – review & editing, Validation, Resources. Zhonghan Wang: Writing – review & editing, Supervision, Resources, Conceptualization. Minfei Wu: Writing – review & editing, Supervision, Funding acquisition, Conceptualization.
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This study was supported by the Department of Science and Technology of Jilin Province ( 20210204104YY ;, YDZJ202201ZYTS281 ;, YDZJ202201ZYTS135 ;, YDZJ202301ZYTS031 ;, YDZJ202301ZYTS032 ) and Scientific Development Program of Jilin Province ( 20240402016 GH ;, 20240602083RC ) and Bethune Plan of Jilin University ( 2023B08 ;, 2023B10 ) and project of the Department of Science and Technology of Jilin Province, with the project identifier YDZJ202401434ZYTS .
IMAGES
VIDEO
COMMENTS
This study has revealed direct evidence of impact of contact time and 58S BAG's crystalline phase on bacterial adhesion and antimicrobial behaviour. ... we repeated the experiment with 3 ...
Abstract. Bacterial attachment to biomaterials is of great interest to the medical and dental field due to its impact on dental implants, dental prostheses, and others, leading to the need to introduce methods for biofilm control and mitigation of infections. Biofilm adhesion is a multifactorial process and involves characteristics relevant to ...
Bacterial populations, programmed to self-assemble by adhesion of nanobody-antigen pairs, can be processed into living materials (LAMBA) that are scalable, self-healing and programmable through ...
In order to detect the change of bacterial adhesion property of the material after different treatments (e.g., surfactant treatment or material modification) using bioluminescence detection, the sample to be tested was treated with surfactant Triton X-100 before the experiment to reduce the adhesion of bacteria to the material. LB liquid media ...
Single-cell RNA sequencing experiments indicate that spatially heterogeneous expression of collagen IV with significant edge effects is responsible for the location-dependent bacterial adhesion ...
This chapter considers methods for the study of adhesion. Consideration is given to model systems, methods for separating adherent from nonadherent cells, controlled and uncontrolled variables in experimental design, and approaches used in analyzing adhesion data. Finally, methods related to the identification and regulation of expression of ...
To study bacterial adhesion onto colloidal substrates, GFP-labeled E. coli cells were brought into contact with cationic particles under gentle stirring, producing mild shear stress on the order of a few tens of piconewtons per contact. While this stirring abolished gravity effects, it also screened cell motility. ... As shown in an experiment ...
Bacterial adhesion to tissue is the starting point for many pathogenic processes and beneficial interactions. ... measurements. To this end, after growth, washing, and dilution the bacteria to OD 600nm <0.5 (see "Preparation of bacteria for adherence experiments" section), 100 µl of each bacterial strain was measured for OD 600 nm ...
Synthetic adhesion to characterize bacterial attachment to host cells. To systematically probe bacterial adhesion to host cells without relying on virulence factors, we engineered an exogenous adhesin in E. coli and cognate receptor in HeLa cells ().As adhesin, we display an anti-GFP nanobody (camelid single-domain variable heavy chain, VHH) using a truncated intimin scaffold 21,22.
Abstract. Bacterial adhesion is the initial step in colonization and biofilm formation. Biofilms can, on the one hand, be detrimental to both human life and industrial processes, for example, causing infection, pathogen contamination, and slime formation, while on the other hand, be beneficial in environmental technologies and bioprocesses.
Hence, bacterial adhesion is predicted energetically unfavourable on the glass surface, while the adhesion on ITO surface is favourable for PS bacteria and unfavourable for SE bacteria. In order to verify the theoretical predictions at contact, adhesion experiments are conducted using a parallel plate flow chamber.
The adhesions between Gram-positive bacteria and their hosts are exposed to varying magnitudes of tensile forces. Here, using an ultrastable magnetic tweezer-based single-molecule approach, we show the catch-bond kinetics of the prototypical adhesion complex of SD-repeat protein G (SdrG) to a peptide from fibrinogen β (Fgβ) over a physiologically important force range from piconewton (pN) to ...
Hence, the presented studies explore bacterial adhesion to abiotic, unconditioned surfaces, i.e., surfaces that are not covered by other biomacromolecules. First, the approaches of understanding bacterial adhesion on the whole cell level, namely in the framework of colloidal science, i.e., surface thermodynamics and DLVO 1 theory, and contact ...
AFM experiments that measured interaction forces between a single bacterium and the tip of the AFM cantilever revealed that these steric interactions can be more important than van der Waals and electrostatic forces for bacterial adhesion, which is related with the initial events of bacterial adhesion onto biomedical devices (Berne et al., 2018).
Understanding bacterial adhesion is important in a number of different areas of study. Here using a range of simulations and experimental methods, the authors, report on the molecular mechanism ...
The first step in bacterial adhesion is the immediate attachment of bacteria onto a substratum which is a reversible, nonspecific process ( 3 - 5 ). This initial interaction between bacteria and artificial surfaces is a key determinant in biofilm formation. If the approach of bacteria to a surface is unfavorable, cells must overcome an energy ...
The Bacterial Adhesion and Corrosion (BAC) spaceflight experiment, planned for launch on SpaceX-21 in December 2020, will study the effect of spaceflight on the formation of multi-species, surface-adherent bacterial communities (biofilms), their ability to corrode stainless steel surfaces relevant to those on the International Space Station (ISS) water system, and the efficacy of disinfectants ...
Experiments include cultivations with E. coli K12 JM109 to reach bacteria adhesion in order to enable adhesion force measurements between bacterium and surface with a new micromanipulation system installed in SEM. To alter the surface, hydrophobic surfaces were generated with Argon/C 4 F 8 plasma. The bacterial adhesion force for untreated ...
The adhesion of bacteria to host tissue is the first step in pathogenesis. Similarly, bacterial adhesion to inanimate surfaces is the first step in formation of biofilms—a real problem in industrial processes and medical devices. ... This was the reason for high S.D. values in the experiments; adhesion of E. coli was 2.80±3.04% and S ...
But from day to day, the percentage of adhesion can vary up to 2-fold. Therefore it is often advisable to use two to three replicate per experiment, plan several experiments and perform statistical analyses using repeated measures or paired tests (either ANOVA or Student's t test). Another key point is the washes after adhesion of bacteria.
Bacterial adhesion is the initial step in surface colonization and community formation. ... We also repeated the experiment with an inoculum composed of only 25 bacterial strains and again found a ...
Bacterial pathogens express various molecules or structures able to promote attachment to host cells (1). These adhesins rely on interactions with host cell surface receptors or soluble proteins acting as a bridge between bacteria and host. Adhesion is a critical first step prior to invasion and/or secretion of toxins, thus it is a key event to ...
Bacterial chemotaxis, a behavioural trait of bacteria, plays a crucial role in adhesion, cell auto-aggregation, and motility processes. ... Experiments were repeated three times independently with similar results. (b) Swimming motility measured by colony diameters of each strain on swimming medium plate. The bars represent standard errors of ...
Recent findings from the World Heart Federation (WHF) reported a significant increase in cardiovascular disease (CVD)-related deaths, highlighting the urgent need for effective prevention strategies. Atherosclerosis, a key precursor to CVD, involves the accumulation of low-density lipoprotein (LDL) and its oxidation within the endothelium, leading to inflammation and foam cell formation.
Mass Transport. For a proper analysis of adhesion data, kinetic and stationary or equilibrium effects must be distinguished. Typical kinetics of any bacterial adhesion experiment follows a pattern as shown in Fig. Fig.1, 1, where an initial linear trajectory can be seen, followed by a leveling off to a (pseudo-) end stage.During the initial phase, organisms that arrive at a substratum surface ...
Cell adhesion experiments are important in tissue engineering and for testing new biologically active surfaces, prostheses, and medical devices. Additionally, the initial state of adhesion ...
Alginate is a polysaccharide mainly derived from brown algae and bacteria and is, widely used in bioprinting because of its excellent ... As a cell adhesion sequence, RGD peptide can bind with integrins on the cell surface, thereby enhancing cell adhesion and interactions within the biological scaffold. ... in other experiments inducing tumor ...